Home > Analytics > SUDEEP PHARMA

SUDEEP PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 544619     NSE : SUDEEPPHRM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Jun 17,2026
Price(EOD): ₹ 871.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 9,840.93 Cr
Value of ₹ 1 Lac invested in SUDEEP PHARMA
on Nov 28,2025 (price: ₹ 773.70)

₹ 1 L

₹ 1.13 L

1W : 19.6% 1M : 34.7% 1Y : NA
COMMUNITY POLL
for SUDEEP PHARMA
Please provide your vote to see the results
SUDEEP PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
SUDEEP PHARMA 19.6% 34.7% NA
SUN PHARMACEUTICAL INDUSTRIES 1.4% -4.5% 6.5%
DIVIS LABORATORIES 0.1% -2.5% -0.1%
TORRENT PHARMACEUTICALS -2.7% 1.2% 39.3%
CIPLA -2.3% -5.3% -9.8%
DR REDDYS LABORATORIES -0.5% -4.7% -5.4%
MANKIND PHARMA -0.3% -5.3% -0.9%
LUPIN -0.3% 0.6% 12.3%
ZYDUS LIFESCIENCES -4% 7.1% 10.2%

FUNDAMENTAL ANALYSIS OF SUDEEP PHARMA

 
Fundamentals Score
[ Q(TTM): Mar2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 SUDEEPPHRM is one of the top 24% companies with good fundamentals ! Discover More →


VALUATION OF SUDEEP PHARMA

 
Valuation Score
[As on : Jun 17,2026 ]

Ratio Consolidated
P/E
P/B
P/S
52.59
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 187.20 Cr
[Latest Qtr - Mar2026 - Consolidated Results ]

11.15
P/B Calculated based on Book Value of Rs 883.34 Cr
[Latest Year - Mar2026 - Consolidated Results ]

14.59
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 674.89 Cr
[Latest Qtr - Mar2026 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 26% undervalued companies ! Discover More →

FAIR VALUE OF SUDEEP PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
92629%
33043%
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF SUDEEP PHARMA


Insights 💡 SUDEEPPHRM is one of the top 37% companies with bullish price momentum currently! Discover More →

SUDEEP PHARMA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF SUDEEP PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0.27
0.17
0.29
0.24
0.27
0.21
0.37
0.28
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF SUDEEP PHARMA

Pledged Promoter Shares
0 %
As on : Mar2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF SUDEEP PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
5.8%
4.38%
1.48%
1.76%
57.82%
59.3%
66.49%
69.06%
QtrlyTrend
8
Latest Qtr: Mar2026
Quarterly Result Analysis →


SUDEEP PHARMA related INDICES

BSE Indices1W1M1Y
BSE IPO 4.5% 6.9% 12.9%
BSE COMMODITIES 2.3% -0.6% 10.5%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 5.4% 7.4% 2.5%
NIFTY SMALLCAP 500 4.5% 5.4% NA
NIFTY TOTAL MARKET 4% 2.8% -0.8%
NIFTY IPO INDEX 3.6% 6.5% 8.3%

You may also like the below Video Courses


FAQ about SUDEEP PHARMA


Is SUDEEP PHARMA good for long term investment?

As on Jun 17,2026, the Fundamentals of SUDEEP PHARMA look Strong and hence it may be good for long term investment! See Financial Performance of SUDEEP PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SUDEEP PHARMA UnderValued or OverValued?

As on Jun 17,2026, SUDEEP PHARMA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SUDEEP PHARMA ?

As on Jun 17,2026, the Intrinsic Value of SUDEEP PHARMA is Rs. 1.79 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 0.94
Fair Value [Median EV / Sales Model] : Rs. 2.63
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of SUDEEP PHARMA : Rs. 1.79

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is SUDEEP PHARMA trading at a Premium or Discount?

As on Jun 17,2026, SUDEEP PHARMA is trading at a Premium of 48698% based on the estimates of Median Intrinsic Value!